Does a biotech company need a fractional CRO or a full-time CRO in 2027?

Direct Answer

Biotech revenue leadership is distinct from SaaS: your buyers are clinicians, lab directors, or procurement at health systems, and sales cycles are long, regulatory-heavy, and often grant-funded. A fractional CRO works well when you need experienced go-to-market strategy, pipeline management, and team building without committing to a full-time executive salary and equity. A full-time CRO becomes necessary when your revenue engine requires daily operational oversight, a growing team of 5+ reps, and consistent board-level accountability. Cost is the primary differentiator—fractional roles let you pay for expertise in blocks, while full-time roles demand a fixed annual burden that can strain a biotech's cash position.

Why biotech is different from SaaS revenue leadership

Biotech companies sell into complex healthcare systems, research institutions, and regulated markets. Your buyers are not typical SaaS procurement teams—they include principal investigators, hospital pharmacy directors, and grant administrators. Sales cycles routinely stretch 9 to 18 months, driven by clinical validation, regulatory approvals, and budget cycles tied to fiscal years. A fractional CRO who has lived through FDA interactions, health system formularies, and reimbursement hurdles brings immediate credibility that a generalist CRO cannot match. Biotech revenue leaders must understand HIPAA, CLIA, and sometimes GMP requirements—these are not optional.

When a fractional CRO makes sense for your biotech

Pre-commercial or early-stage biotechs (pre-revenue to $2M ARR) are the sweet spot for fractional CROs. You need someone to build a go-to-market plan, identify early adopter segments, and coach a small team—but you cannot justify a $350k salary plus benefits and equity. A fractional CRO at 10 days per month can design your sales process, select a CRM (Salesforce or HubSpot), and train your first hires. You avoid the overhead of a full-time executive while getting battle-tested strategy. Many biotechs use fractional CROs to bridge from seed to Series A, then convert to full-time once revenue hits $3M–$5M ARR.

Cash runway is the decisive factor. If you have less than 18 months of operating cash, a full-time CRO's total cost ($300k–$500k with benefits and equity) can consume 10–20% of your burn rate. A fractional engagement preserves capital for R&D, clinical trials, or sales hiring. Biotech investors often prefer fractional leadership at early stages because it demonstrates capital discipline and avoids premature fixed costs.

When you need a full-time CRO

At $5M+ ARR with a proven product and a team of 5+ sales reps, a fractional CRO's limited days per week become a bottleneck. Daily coaching, deal reviews, pipeline management, and board preparation demand a full-time presence. Public biotechs or those with institutional investors (e.g., venture debt, crossover funds) often require a full-time CRO for board-level accountability and SEC compliance. A full-time CRO can also recruit and retain top sales talent—a critical advantage when competing for experienced biotech reps.

Complex sales operations—multi-channel outreach, partner channel management, and territory planning—benefit from a dedicated leader who lives the data daily. If your revenue operations require custom dashboards, Salesforce automation, and regular forecast calls with the CEO, a fractional CRO may struggle to maintain depth.

How to evaluate fractional CRO candidates for biotech

Not all fractional CROs are equal. Look for direct biotech or medtech experience—ideally someone who has sold to health systems, reference labs, or clinical research organizations. Ask about their experience with regulatory sales processes, long-cycle forecasting, and grant-funded purchasing. A strong candidate should name specific tools (Gong for call coaching, Clari for forecasting, Outreach for sequencing) without claiming quantified results. Check their network in Pavilion or RevOps Co-op for peer references. Be wary of any fractional CRO who promises a revenue "playbook" without understanding your specific biology platform and market access path.

The cost trade-off in detail

Fractional CROs charge $8k–$25k per month for 8–15 days of work, depending on scope, company stage, and geography. A biotech in Boston or San Francisco might pay the upper end due to cost of living, while remote fractional CROs may charge less. Full-time CRO compensation in biotech ranges from $250k–$400k base salary plus bonus and equity, with total packages often exceeding $500k at public companies. Equity grants typically vest over 4 years, adding significant long-term cost. For a seed-stage biotech with $3M raised, a fractional CRO at $15k/month for 12 months costs $180k—less than half a full-time CRO's first-year cash cost. That difference can fund a clinical study or two additional sales hires.

The hidden cost of a bad hire is higher for full-time roles. Firing a full-time CRO after 6 months costs severance, lost momentum, and team disruption. Fractional engagements allow you to terminate with 30 days' notice, minimizing risk.

How to transition from fractional to full-time

Many biotechs start fractional and later hire full-time. The transition works best when you define a trigger event—for example, "once we hit $3M ARR and have 4 sales reps, we will hire a full-time CRO." The fractional CRO can help write the job description, interview candidates, and onboard their replacement. Some fractional CROs will accept a full-time role themselves if the equity and mission align. Plan for a 4–8 week overlap where the fractional CRO hands off accounts, processes, and relationships.

FAQ

What if my biotech has no revenue yet? Fractional CROs are ideal for pre-revenue biotechs. They can build your sales playbook, identify early adopter segments, and prepare investor materials without the cost of a full-time executive.

Can a fractional CRO attend board meetings? Yes, most fractional CROs will attend quarterly board meetings as part of their engagement. Some charge extra for board prep or travel.

How do I find a fractional CRO with biotech experience?

Will a fractional CRO use my existing tools? Yes, fractional CROs are tool-agnostic. They will work with Salesforce, HubSpot, Gong, Clari, Outreach, or Salesloft—whatever you have. They may recommend changes based on your stage.

What happens if the fractional CRO gets a full-time offer elsewhere? This is a risk. Mitigate it by signing a 3–6 month contract with a notice period (30–60 days). Many fractional CROs prefer fractional work and will not leave abruptly.

Is a fractional CRO a good fit for a biotech with international sales? Yes, if the fractional CRO has experience with cross-border deals, regulatory differences, and multi-currency forecasting. Confirm their time zone availability.

Sources

• Pavilion — community for revenue leaders with fractional CRO resources
• RevOps Co-op — peer network for revenue operations best practices
• Harvard Business Review — general leadership and organizational design articles
• First Round Review — startup leadership and hiring insights
• SaaStr — go-to-market strategy and CRO role discussions
• LinkedIn — professional network for fractional CRO candidate searches

People also search for: fractional cro · hire a fractional cro · fractional cro near me · fractional cro cost